[HTML][HTML] Cancer stem cells: A brief review of the current status
Cancer stem cells (CSCs) comprise the subpopulation of tumor bulk and acquire resistant to
conventional therapies and are considered as the primary tumor initiator cells. Nowadays …
conventional therapies and are considered as the primary tumor initiator cells. Nowadays …
Exosomes as biomarkers for female reproductive diseases diagnosis and therapy
Cell–cell communication is an essential mechanism for the maintenance and development
of various organs, including the female reproductive system. Today, it is well-known that the …
of various organs, including the female reproductive system. Today, it is well-known that the …
[HTML][HTML] The challenge of targeting cancer stem cells to halt metastasis
A Agliano, A Calvo, C Box - Seminars in Cancer Biology, 2017 - Elsevier
Despite a continuing debate about the existence of cancer stem cells (CSCs), recent
discoveries have provided further support for their existence and their roles in drug …
discoveries have provided further support for their existence and their roles in drug …
Liquid biopsy in endometrial cancer: new opportunities for personalized oncology
L Muinelo-Romay, C Casas-Arozamena… - International journal of …, 2018 - mdpi.com
The identification of new molecular targets and biomarkers associated with high risk of
recurrence and response to therapy represents one of the main clinical challenges in the …
recurrence and response to therapy represents one of the main clinical challenges in the …
Endometrial cancer stem cells: role, characterization and therapeutic implications
G Giannone, L Attademo, G Scotto, S Genta, E Ghisoni… - Cancers, 2019 - mdpi.com
Endometrial cancer (EC) is the most frequent gynecological cancer. In patients with relapsed
and advanced disease, prognosis is still dismal and development of resistance is common …
and advanced disease, prognosis is still dismal and development of resistance is common …
[HTML][HTML] Emerging role of circulating tumor cells in immunotherapy
A Rzhevskiy, A Kapitannikova, P Malinina… - Theranostics, 2021 - ncbi.nlm.nih.gov
Over the last few years, immunotherapy, in particular, immune checkpoint inhibitor therapy,
has revolutionized the treatment of several types of cancer. At the same time, the uptake in …
has revolutionized the treatment of several types of cancer. At the same time, the uptake in …
Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
J Xia, S Li, S Liu, L Zhang - MedComm, 2023 - Wiley Online Library
The family of aldehyde dehydrogenases (ALDHs) contains 19 isozymes and is involved in
the oxidation of endogenous and exogenous aldehydes to carboxylic acids, which …
the oxidation of endogenous and exogenous aldehydes to carboxylic acids, which …
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance
At present, after extensive studies in the field of cancer, cancer stem cells (CSCs) have been
proposed as a major factor in tumor initiation, progression, metastasis, and recurrence …
proposed as a major factor in tumor initiation, progression, metastasis, and recurrence …
[HTML][HTML] MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer
Z Wang, W Wang, K Huang, Y Wang, J Li, X Yang - Oncotarget, 2017 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are small non-coding RNAs composed of 18-25 nucleotides that
regulate the expression of approximately 30% of human protein coding genes …
regulate the expression of approximately 30% of human protein coding genes …
Notch and endometrial cancer
V Jonusiene, A Sasnauskiene - … and Cancer: Notch Signaling in Cancer, 2021 - Springer
The human endometrium is a unique, highly dynamic tissue that undergoes cyclic changes
of cell proliferation, differentiation, and death. Endometrial cancer is the most common …
of cell proliferation, differentiation, and death. Endometrial cancer is the most common …